Drug intelligence / Profile preview

rsu1 siRNA

Development stage
Unknown
Lead developer
The Uniformed Services University of the Health Sciences
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

rsu1 siRNA is a small interfering RNA designed to silence the expression of the Ras suppressor protein 1 (RSU1) gene. RSU1 is a key component of the Integrin-Linked Kinase-PINCH-Parvin (IPP) cell adhesion complex, which plays a critical role in regulating cell adhesion, migration, and signaling. In high-grade gliomas, RSU1 is often deleted or downregulated, contributing to tumor cell invasiveness. siRNA-mediated depletion of RSU1 disrupts the IPP complex, particularly reducing the levels of the binding protein PINCH1, which leads to decreased cell adhesion and enhanced migratory capacity in oncogenic cells. Furthermore, RSU1 depletion has been shown to modulate downstream signaling pathways, including the inhibition of Akt phosphorylation on serine 473 and the regulation of the JNK pathway. It is primarily utilized as a research tool to investigate the molecular mechanisms of tumor progression and the functional consequences of chromosome 10p13 deletions in glioblastoma.

Other names
RSU1 siRNARSU-1 siRNARSU 1 siRNARas suppressor protein 1 siRNARSU1 small interfering RNARSU-1 small interfering RNARSU 1 small interfering RNA
02

Targets

RSU1 (Ras suppressor protein 1 mRNA)

Beyond the preview

Go deeper on rsu1 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rsu1 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call